Metastases and Recurrence Risk Factors in Endometrial Cancer-The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures

被引:1
|
作者
Markowska, Anna [1 ]
Baranowski, Wlodzimierz [2 ]
Pitynski, Kazimierz [3 ]
Chudecka-Glaz, Anita [4 ]
Markowska, Janina [5 ]
Sawicki, Wlodzimierz [6 ]
Srivastava, Sanjay K.
机构
[1] Poznan Univ Med Sci, Dept Perinatol & Womens Dis, PL-60535 Poznan, Poland
[2] Mil Inst Med, Dept Gynecol Oncol, PL-04141 Warsaw, Poland
[3] Jagiellonian Univ Med Coll, Dept Gynecol & Oncol, PL-31501 Krakow, Poland
[4] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adolesc, PL-70204 Szczecin, Poland
[5] Gynecol Oncol Ctr Poznan, Poznanska 58A, PL-60850 Poznan, Poland
[6] Med Univ Warsaw, Dept Obstet Gynecol & Gynecol Oncol, Warsaw, Poland
关键词
endometrial cancer metastasis; TCGA classification; hormones; ultrasonography; hysteroscopy; LYMPH-NODE METASTASIS; PREOPERATIVE PREDICTION; MYOMETRIAL INVASION; HYSTEROSCOPY; CARCINOMA; ULTRASOUND; GRADE; CELLS; DISSEMINATION; MODEL;
D O I
10.3390/cancers16010179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This paper delves into the issue of metastatic endometrial cancer (EC), which significantly impacts treatment success and overall survival rates. The study explores various factors contributing to metastasis, including the molecular profile of EC, hormone activity (like estrogen and prolactin), and pro-inflammatory adipocytokines. It also investigates how altered microRNA expression affects gene regulation linked to the dissemination of the cancer. The paper highlights the importance of imaging techniques, particularly transvaginal ultrasound with tumor-free distance (uTFD), in detecting metastases. Additionally, it discusses how diagnostic and therapeutic methods can influence the spread of EC, with hysteroscopy potentially increasing risk in advanced stages and laparoscopic hysterectomy being safer if performed with care. This research could improve our understanding of EC and guide better diagnostic and treatment strategies.Abstract The presence of metastatic endometrial cancer (EC) is a key problem in treatment failure associated with reduced overall survival rates. The most common metastatic location is the pelvic lymph nodes, and the least common is the brain. The presence of metastasis depends on many factors, including the molecular profile of cancer (according to the TCGA-Genome Atlas), the activity of certain hormones (estrogen, prolactin), and pro-inflammatory adipocytokines. Additionally, an altered expression of microRNAs affecting the regulation of numerous genes is also related to the spread of cancer. This paper also discusses the value of imaging methods in detecting metastases; the primary role is attributed to the standard transvaginal USG with the tumor-free distance (uTFD) option. The influence of diagnostic and therapeutic methods on EC spread is also described. Hysteroscopy, according to the analysis discussed above, may increase the risk of metastases through a fluid medium, mainly performed in advanced stages of EC. According to another analysis, laparoscopic hysterectomy performed with particular attention to avoiding risky procedures (trocar flushing, tissue traumatization, preserving a margin of normal tissue) was not found to increase the risk of EC dissemination.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The role of selected risk factors for development of oesophageal cancer
    Kollarova, Helena
    Azeem, Katerina
    Magnuskova, Silvie
    Tomaskova, Hana
    Sevcikova, Jarmila
    Horakova, Dagmar
    Kamarad, Vojtech
    Janout, Vladimir
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2013, 8 (01): : 30 - 40
  • [22] Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment
    Jang, Eun Bi
    Kook, Yoon Sun
    Jung, Soo Jin
    Lee, A. Jin
    So, Kyeong A.
    Lee, Sun Joo
    Lee, Ji Young
    Kim, Tae Jin
    Kang, Soon-Beom
    Shim, Seung-Hyuk
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A16 - A16
  • [23] Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment
    Jang, Eun Bi
    Lee, A. Jin
    So, Kyeong A.
    Lee, Sun Joo
    Lee, Ji Young
    Kim, Tae Jin
    Park, Eunhyang
    Kang, Soon-Beom
    Shim, Seung-Hyuk
    GYNECOLOGIC ONCOLOGY, 2024, 191 : 19 - 24
  • [24] Clinical review 139 - Endometrial cancer: Hormonal factors, the perimenopausal "window of risk," and isoflavones
    Hale, GE
    Hughes, CL
    Cline, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01): : 3 - 15
  • [25] Risk Factors for Recurrence in Low-Risk Endometrial Cancer: A Case-Control Study
    Gungorduk, Kemal
    Cuylan, Zeliha Firat
    Kahramanoglu, Ilker
    Oge, Tufan
    Akbayir, Ozgur
    Dede, Murat
    Taskin, Salih
    Ozgul, Nejat
    Simsek, Tayup
    Turan, Hasan
    Gulseren, Varol
    Ozdemir, Aykut
    Meydanli, Mehmet M.
    Ayhan, Ali
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (7-8) : 466 - 470
  • [26] THE ROLE OF NESFATIN 1 IN ENDOMETRIAL CANCER AND ITS CORRELATION WITH SELECTED MOLECULAR FACTORS - A MULTI-CENTRE STUDY
    Markowska, J.
    Szarszewska, M.
    Marszalek, A.
    Filas, W.
    Jozwik, M.
    Olejek, A.
    Bednarek, W.
    Jach, R.
    Grybos, A.
    Sozanski, R.
    Wojcik-Krowiranda, K.
    Madry, R.
    Markowska, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1131 - 1131
  • [27] Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors
    Lamartina, Livia
    Borget, Isabelle
    Mirghani, Haitham
    Al Ghuzlan, Abir
    Berdelou, Amandine
    Bidault, Francois
    Deandreis, Desiree
    Baudin, Eric
    Travagli, Jean-Paul
    Schlumberger, Martin
    Hartl, Dana M.
    Leboulleux, Sophie
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (03): : 1020 - 1031
  • [28] Early recurrence after surgery in FIGO 2023 stage I-III endometrial cancer: characteristics and risk factors
    Huang, Zhen
    Li, Xue
    Li, Ling
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [29] Risk Factors for Para-Aortic Lymph Node Metastases in Patients with Endometrial Cancer
    Bacalbasa, Nicolae
    Balescu, Irina
    Tanase, Alina
    Vilcu, Mihaela
    Brasoveanu, Vladislav
    Brezean, Iulian
    Suciu, Nicolae
    PROCEEDINGS OF SOGR 2018: THE 17TH NATIONAL CONGRESS OF THE ROMANIAN SOCIETY OF OBSTETRICS AND GYNECOLOGY & FIRST ADVANCED COLPOSCOPY COURSE, 2019, : 83 - 87
  • [30] Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors
    Ben Arie, A.
    Lavie, O.
    Gdalevich, M.
    Voldarsky, M.
    Barak, F.
    Schneider, D.
    Levy, T.
    Anteby, E.
    Gemer, O.
    EJSO, 2012, 38 (02): : 166 - 169